These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22430948)

  • 21. Clinical management of older persons with haemophilia.
    Hermans C; de Moerloose P; Dolan G
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):197-206. PubMed ID: 23953685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
    McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
    Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemophilia gene transfer: comparison with conventional protein replacement therapy.
    Ragni MV
    Semin Thromb Hemost; 2004 Apr; 30(2):239-47. PubMed ID: 15118935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemophilia A.
    Lusher JM; Warrier I
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1021-33. PubMed ID: 1400070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(1):19-25. PubMed ID: 7796372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The management of hemophilia in elderly patients.
    Franchini M; Tagliaferri A; Mannucci PM
    Clin Interv Aging; 2007; 2(3):361-8. PubMed ID: 18044186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk assessment in haemophilia patients.
    Biere-Rafi S; Baarslag MA; Peters M; Kruip MJ; Kraaijenhagen RA; Den Heijer M; Büller HR; Kamphuisen PW
    Thromb Haemost; 2011 Feb; 105(2):274-8. PubMed ID: 21136012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do patients with haemophilia undergoing cardiac surgery have good surgical outcomes?
    Rossi M; Jayaram R; Sayeed R
    Interact Cardiovasc Thorac Surg; 2011 Sep; 13(3):320-31. PubMed ID: 21712351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical complications of hemophilia.
    White GC; Blatt PM; McMillan CW; Webster WP; Lesesne HR; Roberts HR
    South Med J; 1980 Feb; 73(2):155-60. PubMed ID: 6766570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Musculoskeletal manifestations of hemophilia: imaging features.
    Jaganathan S; Gamanagatti S; Goyal A
    Curr Probl Diagn Radiol; 2011; 40(5):191-7. PubMed ID: 21787985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controversial subjects in musculoskeletal care of haemophilia: cross fire.
    Llinás A; Silva M; Pasta G; Luck JV; Asencio JG; Fernandez Palazzi F; Caviglia H; Manco-Johnson M; Seuser A
    Haemophilia; 2010 Jul; 16 Suppl 5():132-5. PubMed ID: 20590872
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of bleeding disorders in the elderly.
    Kruse-Jarres R; Quon D; Schramm W; Dolan G
    Haemophilia; 2012 May; 18 Suppl 2():37-45. PubMed ID: 22530577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive care for patients with hemophilia: an expanded role in reducing risk for human immunodeficiency virus.
    Hoots WK; Buchanan GR; Parmley RT; Alperin JB; Kletzel M; Sexauer CL
    Tex Med; 1991 Jun; 87(6):73-5. PubMed ID: 1877032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemophilia and ageing.
    Street A; Hill K; Sussex B; Warner M; Scully MF
    Haemophilia; 2006 Jul; 12 Suppl 3():8-12. PubMed ID: 16683991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemophilia treatment in developing countries: products and protocols.
    Srivastava A; You SK; Ayob Y; Chuansumrit A; de Bosch N; Perez Bianco R; Ala F
    Semin Thromb Hemost; 2005 Nov; 31(5):495-500. PubMed ID: 16276456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemophilia and cancer: a new challenge for hemophilia centers.
    Franchini M; Lippi G; Montagnana M; Targher G; Zaffanello M; Salvagno GL; Rivolta GF; Perna CD; Tagliaferri A
    Cancer Treat Rev; 2009 Jun; 35(4):374-7. PubMed ID: 19195788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and risk factors for heart disease among males with hemophilia.
    Kulkarni R; Soucie JM; Evatt BL;
    Am J Hematol; 2005 May; 79(1):36-42. PubMed ID: 15849761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemophilia: pathophysiology and musculoskeletal complications.
    Pelligra SJ
    South Med J; 1987 Sep; 80(9):1148-52. PubMed ID: 3629319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Renal, hepatic, biliary, and cardiovascular emergencies in onco-haematology].
    Nitenberg G; Blot F; Raynard B
    Rev Prat; 2003 Dec; 53(19):2160-70. PubMed ID: 15008473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.